RE: next update22 Apr 2022 11:56
For me the 1.2M off the table was very significant indeed. I was never after a stock that might achieve profitability in 3 years, that stock may be worth a small position but does not warrant a large one.
Clearly investors like myself drew a growth line from almost nothing to that 1.2M and advanced it forward, and that was very attractive indeed.
Previous to that we were told (and I was actually there), that pre-registration numbers were "going up at an alarming rate" , with the emphasis being highly positive. Along with "we are already Wincloves second largest customer and likely to become the largest". Well I knew a handful who pre-registered and they all purchased, and knew that was highly likely to be emulated . Clearly it was not, but knowing how nasty this psoriasis condition is, and know from experience how much sufferers hunt out decent treatments I find it actually unbelievable that we actually did have high numbers. In my book this really throws up a huge red flag, that numbers were in fact small, but investors not given accurate information. Indeed the more private correspondence talking of 50k numbers were indeed total B/S. and I was misled. Even in Jan some good posters believed that numbers were high but the small amount of factual data from batch numbers pointed at the opposite. This was via private messaging. I still have the current information and was very close indeed when the hard numbers were announced previously, and I can see that numbers are certainly going up faster now, but still an order of magnitude from previous expectations. Yep they may not be accurate, but I was pretty much spot on previously so unless something else has changed, I believe them. However it is still very early days and hasnt had a decent amount of time to try and get a toehold in the USA market, with the proper launch only a couple of months old.
Just my honest point of view.
Sign In
Follow the stocks
